Doxycycline to Protect Heart Muscle After Heart Attacks

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.

Also called NCT03508232

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 174 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03508232
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03508232. Randomized; quadruple masking; primary purpose prevention. Start 2020-01-06 (actual); primary completion 2025-07-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Doxycycline to Protect Heart Muscle After Heart Attacks
Condition
ST Segment Elevation Myocardial Infarction
Condition
Heart Failure
Intervention (Drug)
Placebo
Intervention (Drug)
Doxycycline Hyclate
Lead sponsor
University of Alberta (class: other)
Collaborator
Royal Alexandra Hospital (class: other)

Record details

Record id
cardio:ct-nct03508232
Content hash
d5b89318c166e0f758be2b9988122bda556862f1bf91c7e41bd658fac074234b